Linking obesity to colorectal cancer: Recent insights into plausible biological mechanisms

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 5, 2013, Pages 595-600

  Guffey, Catherine R ^a   Fan, Daping ^a   Singh, Udai P ^a   Murphy, E Angela ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

adipokines; colorectal cancer; estrogen; inflammation; obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ESTROGEN; ESTROGEN RECEPTOR BETA; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; CANCER RISK; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL POLYP; CYTOKINE RELEASE; HUMAN; INFLAMMATION; MACROPHAGE; OBESITY; REVIEW;

EID: 84883300849     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328362d10b     Document Type: Review

References (45)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225-249.
2. Jafri SH, Mills G. Lifestyle modification in colorectal cancer patients: An integrative oncology approach. Future Oncol 2013; 9:207-218.
3. Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: A systematic review of prospective studies. PLoS One 2013; 8:e53916.
4. Rickles AS, Iannuzzi JC, Mironov O, et al. Visceral obesity and colorectal cancer: Are we missing the boat with BMI? J Gastrointest Surg 2013; 17:133-143.
5. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. J Am Med Assoc 2012; 307:483-490.
6. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. J Am Med Assoc 2012; 307:491-497.
7. Grizzi F, Bianchi P, Malesci A, Laghi L. Prognostic value of innate and adaptive immunity in colorectal cancer. World J Gastroenterol 2013; 19:174-184.
8. Okayama H Schetter AJ Harris CC. MicroRNAs and inflammation in the pathogenesis and progression of colon cancer. Dig Dis 2012; 30 (Suppl 2): 9-15.
9. Balkwill FR, Mantovani A. Cancer-related inflammation: Common themes and therapeutic opportunities. Semin Cancer Biol 2012; 22:33-40.
10. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117:175-184.
11. Oh DY, Morinaga H, Talukdar S, et al. Increased macrophage migration into adipose tissue in obese mice. Diabetes 2012; 61:346-354.
12. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796-1808.
13. Enos RT, Davis JM, Velazquez KT, et al. Influence of dietary saturated fat content on adiposity, macrophage behavior, inflammation, and metabolism: Composition matters. J Lipid Res 2013; 54:152-163.
14. Liu Z, Brooks RS, Ciappio ED, et al. Diet-induced obesity elevates colonic TNF-alpha in mice and is accompanied by an activation of Wnt signaling: A mechanism for obesity-associated colorectal cancer. J Nutr Biochem 2012; 23:1207-1213.
15. Flores MB, Rocha GZ, Damas-Souza DM, et al. Obesity-induced increase in tumor necrosis factor-alpha leads to development of colon cancer in mice. Gastroenterology 2012; 143:741-753; e4.
16. Pendyala S, Neff LM, Suarez-Farinas M, Holt PR ,Diet-induced Weight Loss Reduces Colorectal Inflammation: Implications for Colorectal Carcinogenesis. Am J Clin Nutr 2011; 93:234-242.
17. Hillenbrand A, Fassler J, Huber N, et al. Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls. BMC Cancer 2012; 12:545.
18. Hopkins MH, Flanders WD, Bostick RM. Associations of circulating inflammatory biomarkers with risk factors for colorectal cancer in colorectal adenoma patients. Biomark Insights 2012; 7:143-150.
19. Ono M. Molecular links between tumor angiogenesis and inflammation: Inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 2008; 99:1501-1506.
20. Yoshidome H, Kohno H, Shida T, et al. Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases. Int J Oncol 2009; 34:923-930.
21. McClellan JL, Davis JM, Steiner JL, et al. Intestinal inflammatory cytokine response in relation to tumorigenesis in the Apc(Min/?) mouse. Cytokine 2012; 57:113-119.
22. McClellan JL, Davis JM, Steiner JL, et al. Linking tumor associated macrophages, inflammation, and intestinal tumorigenesis: Role of MCP-1. Am J Physiol Gastrointest Liver Physiol 2012; 303:G1087-G1095.
23. Bailey C, Negus R, Morris A, et al. Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer. Clin Exp Metastasis 2007; 24:121-130.
24. Kantola T, Klintrup K, Vayrynen JP, et al. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer 2012; 107:1729-1736.
25. Ghosh S, Ashcraft K. An IL-6 link between obesity and cancer. Front Biosci (Elite Ed) 2013; 5:461-478.
26. Waldner MJ, Foersch S, Neurath MF. Interleukin-6: A key regulator of colorectal cancer development. Int J Biol Sci 2012; 8:1248-1253.
27. Guthrie GJ, Roxburgh CS, Horgan PG, McMillan DC. Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer? Cancer Treat Rev 2013; 39:89-96.
28. Baltgalvis KA, Berger FG, Pena MM, et al. Interleukin-6 and cachexia in ApcMin/? mice. Am J Physiol Regul Integr Comp Physiol 2008; 294:R393-R401.
29. Lee WS, Baek JH, You DH, Nam MJ. Prognostic value of circulating cytokines for stage III colon cancer. J Surg Res 2013; 182:49-54.
30. Sasaki Y, Takeda H, Sato T, et al. Serum Interleukin-6, insulin, and HOMA-IR in male individuals with colorectal adenoma. Clin Cancer Res 2012; 18:392-399.
31. Li Y, de Haar C, Chen M, et al. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut 2010; 59:227-235.
32. Saxena A, Chumanevich A, Fletcher E, et al. Adiponectin deficiency: Role in chronic inflammation induced colon cancer. Biochim Biophys Acta 2012; 1822:527-536.
33. Moon HS, Liu X, Nagel JM, et al. Salutary effects of adiponectin on colon cancer: In vivo and in vitro studies in mice. Gut 2013; 62:561-570.
34. Gonullu G, Kahraman H, Bedir A, et al. Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis 2010; 25:205-212.
35. Aleksandrova K, Boeing H, Jenab M, et al. Total and high-molecular weight adiponectin and risk of colorectal cancer: The European Prospective Investigation into Cancer and Nutrition Study. Carcinogenesis 2012; 33:1211-1218.
36. Fenton JI, Hursting SD, Perkins SN, HordNG. Leptin induces an Apc genotypeassociated colon epithelial cell chemokine production pattern associated with macrophage chemotaxis and activation. Carcinogenesis 2007; 28:455-464.
37. Aparicio T, Kotelevets L, Tsocas A, et al. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/?) mice. Gut 2005; 54:1136-1145.
38. Endo H, Hosono K, Uchiyama T, et al. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut 2011; 60:1363-1371.
39. Aleksandrova K, Boeing H, Jenab M, et al. Leptin and soluble leptin receptor in risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort. Cancer Res 2012; 72:5328-5337.
40. Ho GY, Wang T, Gunter MJ, et al. Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res 2012; 72:3029-3037.
41. Saleiro D, Murillo G, Benya RV, et al. Estrogen receptor-beta protects against colitis-associated neoplasia in mice. Int J Cancer 2012; 131:2553-2561.
42. Heijmans J, Wielenga MC, Rosekrans SL, et al. Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer. Gut 2013. (in press).
43. Rudolph A, Toth C, Hoffmeister M, et al. Expression of oestrogen receptor beta and prognosis of colorectal cancer. Br J Cancer 2012; 107:831-839.
44. Fang YJ Zhang L Wu XJ et al. Impact of ERbeta and CD44 expression on the prognosis of patients with stage II colon cancer. Tumour Biol 2012; 33:1907-1914.
45. Lin JH, Morikawa T, Chan AT, et al. Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression. Cancer Res 2012; 72:3020-3028.